Katasha Jarrin
Family · Fayetteville, NCNPI 1154865251
Payments from drug & device makers
Across 52 payments — averaging $40.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$380
- Alkermes, Inc.$190
- Indivior Inc.$183
- Sanofi-aventis U.S. LLC$178
- Amgen$157
- Tris Pharma Inc$152
- plus $863 from 17 others
What the payments were for
- Food & beverage$2,094100%
- Education$90%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $380 |
| Alkermes, Inc. | 5 | $190 |
| Indivior Inc. | 7 | $183 |
| Sanofi-aventis U.S. LLC | 3 | $178 |
| Amgen | 5 | $157 |
| Tris Pharma Inc | 3 | $152 |
| Lexicon Pharmaceuticals, Inc. | 1 | $125 |
| Eisai Inc. | 1 | $122 |
| AstraZeneca | 1 | $120 |
| Corcept Therapeutics | 1 | $115 |
| Teva Pharmaceuticals USA, Inc. | 6 | $97 |
| AbbVie | 4 | $86 |
| Biogen | 1 | $27 |
| Braeburn Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $20 |
| Merck | 1 | $18 |
| Novo Nordisk | 1 | $18 |
| Almatica Pharma LLC | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Ironwood Pharmaceuticals, Inc | 1 | $16 |
| Exact Sciences | 1 | $15 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAPLYTA$357
- Inpefa$125
- TZIELD$125
- Leqembi$122
- FARXIGA$120
- VIVITROL$120
- Dyanavel XR$120
- Quillivant$120
- Quillichew ER$120
- Korlym$115
- Otezla$100
How this compares
$2,103 in reported general payments places this provider in the 80th percentile of 4,522 family providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 16 | $1,825 |
| Bupropion XlBupropion Hcl | 19 | $142 |
Paid to pharmacies, not to this prescriber.
Other family in Fayetteville
- Leslie ByrneFayetteville$482K
- Melissa DoyleFayetteville$38K
- Michele CerraRaleigh$332K
- Anne LakeArchdale$306K
- Carrie PettitRaleigh$298K
- Nicole RothmanDurham$268K
- Meredith LeaYanceyville$253K
- Jennifer GibbsRaleigh$216K
- Juanita PerkinsDurham$213K
- Teresa DossWilmington$137K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.